Skip to main navigation
Fate Therapeutics, Inc.
  • About Us
    • Overview
    • Leadership
    • Corporate Responsibility
  • Pipeline
    • Overview
    • Product Candidates
      • FT819
      • FT825
      • FT836
      • FT829
      • FT522
    • Early/Expanded Access Policy
  • Science
    • Our Cells of Interest
    • iPSC Platform
    • Manufacturing
    • Publications & Presentations
  • Patients
    • Our Commitment
    • Our Therapy
    • Autoimmune Disease
    • Cancer
    • Clinical Trials
  • Collaborations
  • Careers and Culture
    • The Fate Way
    • Join Our Team
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxies
    • Corporate Governance
    • Stock Information
      • Historical Stock Lookup
    • Investors FAQs
  • Contact
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial & Filings
      • SEC Filings
      • Annual Reports and Proxies
    • Corporate Governance
    • Stock Information
    • Investors FAQs

Financials & Filings

ANNUAL REPORTS

Title View
2024 Annual Report 3 MB
2024 Annual Report 3 MB
2023 Annual Report 8.2 MB
2023 Annual Report 8.2 MB

PROXY STATEMENTS

Filing date View
Apr 26, 2024 View HTML
0001193125-24-117981.pdf
0001193125-24-117981.xls
Apr 21, 2023 View HTML
0001193125-23-110475.pdf
0001193125-23-110475.xls

FORM 10-K

Filing date View
Feb 26, 2026 View HTML
0001193125-26-073699.pdf
0001193125-26-073699.xls
Mar 05, 2025 View HTML
0000950170-25-033510.pdf
0000950170-25-033510.xls

FORM 10-Q

Filing date View
Nov 13, 2025 View HTML
0001193125-25-279096.pdf
0001193125-25-279096.xls
Aug 12, 2025 View HTML
0000950170-25-107309.pdf
0000950170-25-107309.xls

Shareholder Tools

Printed Materials
Email Alerts
Download Library
RSS News Feeds
Print Page
Share
Search

  • Facebook
  • LinkedIn
  • Twitter
  • RSS

© 2026 Fate Therapeutics | 12278 Scripps Summit Drive, San Diego, CA 92131 | 866.875.1833 | LEGAL

MENU
  • About Us
    • Overview
    • Leadership
    • Corporate Responsibility
  • Pipeline
    • Overview
    • Product Candidates
      • FT819
      • FT825
      • FT836
      • FT829
      • FT522
    • Early/Expanded Access Policy
  • Science
    • Our Cells of Interest
    • iPSC Platform
    • Manufacturing
    • Publications & Presentations
  • Patients
    • Our Commitment
    • Our Therapy
    • Autoimmune Disease
    • Cancer
    • Clinical Trials
  • Collaborations
  • Careers and Culture
    • The Fate Way
    • Join Our Team
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxies
    • Corporate Governance
    • Stock Information
      • Historical Stock Lookup
    • Investors FAQs
  • Contact